Verification of the Short-Term Impact of Imeglimin on Liver Fibrosis Markers Stratified by Liver Fib...
Verification of the Short-Term Impact of Imeglimin on Liver Fibrosis Markers Stratified by Liver Fibrosis Risk in Patients With Type 2 Diabetes
About this item
Full title
Author / Creator
Publisher
United States: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Objective This study aimed to evaluate the effects of imeglimin on Fibrosis-4 index (FIB-4) and aspartate aminotransferase to platelet ratio index (APRI) across three subgroups classified according to the FIB-4 classification for assessing liver fibrosis risk in patients with type 2 diabetes mellitus (T2DM). Materials and methods Eighty-three patie...
Alternative Titles
Full title
Verification of the Short-Term Impact of Imeglimin on Liver Fibrosis Markers Stratified by Liver Fibrosis Risk in Patients With Type 2 Diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12091082
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_12091082
Other Identifiers
ISSN
2168-8184
E-ISSN
2168-8184
DOI
10.7759/cureus.82625
